Clinical Trial

Evaluate the Efficacy and Safety of NT-0796 in Participants With Obesity With or Without Type 2 Diabetes Mellitus

Study acronym: RESOLVE-1
Completed Phase 2
View on ClinicalTrials.gov →
Summary
A Phase 2a Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of NT-0796 as an Adjunct to a Reduced Calorie Diet and Increased Physical Activity in Obese Participants With/Without Type 2 Diabetes over a 6 months treatment period.
Protocol Amendment History 1 change
critical Trial completed 2026-07-01
Trial Details
NCT Number NCT07055516
Lead Sponsor NodThera Limited
Conditions Obesity and Type 2 Diabetes
Enrollment 176 participants
Start Date 2025-05-08
Primary Completion 2026-05-27 (estimated)
Study Completion 2026-05-27 (estimated)
Updated on ClinicalTrials.gov 2026-06-30